X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (194455) 194455
Book Review (28285) 28285
Newsletter (14876) 14876
Publication (14306) 14306
Conference Proceeding (811) 811
Book / eBook (508) 508
Book Chapter (502) 502
Magazine Article (435) 435
Newspaper Article (213) 213
Web Resource (127) 127
Dissertation (97) 97
Trade Publication Article (63) 63
Paper (26) 26
Transcript (25) 25
Reference (17) 17
Streaming Video (17) 17
Journal / eJournal (13) 13
Data Set (10) 10
Government Document (3) 3
Report (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (179390) 179390
humans (154806) 154806
antineoplastic agents - pharmacology (96866) 96866
animals (80170) 80170
cancer (56315) 56315
oncology (54587) 54587
cell line, tumor (53053) 53053
female (50127) 50127
pharmacology & pharmacy (46694) 46694
mice (43916) 43916
male (37366) 37366
antineoplastic agents (36374) 36374
apoptosis (33507) 33507
antineoplastic agents - therapeutic use (32040) 32040
antimitotic agents (30205) 30205
apoptosis - drug effects (29127) 29127
antineoplastic agents - chemistry (26477) 26477
chemotherapy (25884) 25884
cell proliferation - drug effects (25360) 25360
research (22813) 22813
chemistry, medicinal (22797) 22797
care and treatment (20946) 20946
biochemistry & molecular biology (20266) 20266
dose-response relationship, drug (20026) 20026
neoplasms - drug therapy (19906) 19906
cell survival - drug effects (19146) 19146
antineoplastic agents, phytogenic - pharmacology (18238) 18238
middle aged (17953) 17953
tumor cells, cultured (17632) 17632
drug screening assays, antitumor (17402) 17402
analysis (16345) 16345
expression (16027) 16027
aged (15346) 15346
antineoplastic agents - chemical synthesis (15299) 15299
adult (14654) 14654
structure-activity relationship (14282) 14282
antineoplastic agents - administration & dosage (13872) 13872
in-vitro (13104) 13104
tumors (13078) 13078
rats (13069) 13069
molecular structure (12620) 12620
health aspects (12538) 12538
cells (11947) 11947
cytotoxicity (11731) 11731
mice, nude (10959) 10959
drug resistance, neoplasm (10875) 10875
breast neoplasms - drug therapy (10826) 10826
therapy (10647) 10647
cell biology (10529) 10529
drugs (10497) 10497
xenograft model antitumor assays (10492) 10492
drug therapy (10489) 10489
signal transduction - drug effects (10358) 10358
antineoplastic agents - adverse effects (10165) 10165
breast cancer (10129) 10129
article (10046) 10046
treatment outcome (9909) 9909
proteins (9691) 9691
inhibition (9468) 9468
antineoplastic combined chemotherapy protocols - therapeutic use (9449) 9449
growth (9378) 9378
activation (9207) 9207
cisplatin (8529) 8529
time factors (8450) 8450
drug synergism (8415) 8415
oncology, experimental (8272) 8272
metastasis (8232) 8232
breast-cancer (8194) 8194
medicine & public health (8040) 8040
mice, inbred balb c (7938) 7938
cell cycle - drug effects (7781) 7781
antineoplastic agents - pharmacokinetics (7761) 7761
chemistry, multidisciplinary (7752) 7752
cell division - drug effects (7682) 7682
drug resistance (7592) 7592
lung neoplasms - drug therapy (7516) 7516
cisplatin - pharmacology (7479) 7479
pharmacology (7376) 7376
pharmacology/toxicology (7246) 7246
in-vivo (7203) 7203
carcinoma (7057) 7057
breast neoplasms - pathology (6986) 6986
phosphorylation (6971) 6971
signal transduction (6854) 6854
cell line (6845) 6845
enzyme inhibitors - pharmacology (6844) 6844
gene expression (6826) 6826
blotting, western (6666) 6666
flow cytometry (6651) 6651
chemistry, organic (6541) 6541
drug delivery systems (6533) 6533
resistance (6526) 6526
cell cycle (6471) 6471
gene expression regulation, neoplastic - drug effects (6463) 6463
toxicity (6448) 6448
inhibitory concentration 50 (6445) 6445
medicine, research & experimental (6426) 6426
doxorubicin - pharmacology (6381) 6381
hematology (6298) 6298
neoplasms - metabolism (6293) 6293
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (272) 272
Online Resources - Online (128) 128
Collection Dvlpm't (Acquisitions) - Vendor file (26) 26
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (24) 24
Collection Dvlpm't (Acquisitions) - Closed Orders (22) 22
UofT at Mississauga - Stacks (9) 9
Gerstein Science - Periodical Stacks (8) 8
Chemistry (A D Allen) - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
East Asian (Cheng Yu Tung) - Reference (2) 2
Gerstein Science - Bindery (2) 2
Gerstein Science - Circulation Desk (2) 2
Lakeridge Health Sciences - Online (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - Online (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Stacks (1) 1
Gerstein Science - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (202364) 202364
Chinese (3107) 3107
Japanese (1519) 1519
German (1189) 1189
Russian (1076) 1076
French (705) 705
Italian (307) 307
Polish (196) 196
Spanish (192) 192
Hungarian (86) 86
Czech (63) 63
Ukrainian (41) 41
Dutch (38) 38
Swedish (21) 21
Romanian (17) 17
Slovak (17) 17
Norwegian (13) 13
Portuguese (11) 11
Hebrew (9) 9
Bulgarian (8) 8
Danish (8) 8
Croatian (7) 7
Finnish (7) 7
Korean (5) 5
Serbian (5) 5
Turkish (4) 4
Greek (2) 2
Afrikaans (1) 1
Amharic (1) 1
Kurdish (1) 1
Lithuanian (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer chemotherapy and pharmacology, ISSN 0344-5704
Journal
Science, ISSN 0036-8075, 2/2013, Volume 339, Issue 6119, pp. 587 - 590
Journal Article
Journal Article
Advanced Materials, ISSN 0935-9648, 03/2013, Volume 25, Issue 9, pp. 1353 - 1359
A new generation of photothermal therapeutic agents based on biopolymer dopamine-melanin colloidal nanospheres is described. Benefitting from their naturally... 
nanomaterials | polymers | biocompatibility | dopamine-melanin | photothermal therapy | CELLS | HYPERTHERMIA | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | CONTRAST AGENTS | LASER | MATERIALS SCIENCE, MULTIDISCIPLINARY | GOLD NANORODS | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | PORPHYSOME NANOVESICLES | NANOPARTICLES | SPECTROSCOPY | NANOSHELLS | ABLATION | Dopamine - chemistry | Colloids - chemistry | Temperature | Melanins - chemistry | Humans | Nanospheres - chemistry | Structure-Activity Relationship | Colloids - pharmacology | Dose-Response Relationship, Drug | Time Factors | Lasers | Surface Properties | Mammary Neoplasms, Experimental - pathology | Antineoplastic Agents - pharmacology | Mammary Neoplasms, Experimental - drug therapy | Cell Survival - drug effects | Dopamine - pharmacology | Antineoplastic Agents - chemistry | Melanins - pharmacology | Phototherapy | Particle Size | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | HeLa Cells | Antimitotic agents | Care and treatment | Dopamine | Phenols | Antineoplastic agents | Polymers | Health aspects | Nanotechnology | Cancer | Index Medicus | Surgical implants | Nanospheres | Colloids | Biocompatibility | Pharmacology | Damage | Density | Chemical compounds
Journal Article
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 11/2013, Volume 135, Issue 46, pp. 17617 - 17629
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2013, Volume 19, Issue 2, pp. 202 - 208
Journal Article
Journal Article
Nature Nanotechnology, ISSN 1748-3387, 04/2016, Volume 11, Issue 4, pp. 378 - 387
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 1, pp. 32 - 42
Ibrutinib inhibits Bruton's tyrosine kinase, a component of normal B-cell activation pathways. Ibrutinib produced responses in 71% of patients with refractory... 
MEDICINE, GENERAL & INTERNAL | BRUTONS TYROSINE KINASE | ACTIVATION | RITUXIMAB | B-CELL MALIGNANCIES | PCI-32765 | SURVIVAL SIGNALS | KAPPA-B | INHIBITOR | ANTIGEN RECEPTOR | FLUDARABINE | Recurrence | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Pyrazoles - pharmacokinetics | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Treatment Outcome | Pyrimidines - pharmacology | Remission Induction | Disease-Free Survival | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Chronic lymphocytic leukemia | Care and treatment | Product development | Antineoplastic agents | Tyrosine | Cell proliferation | Pharmacodynamics | Chronic lymphatic leukemia | Cell survival | Risk groups | Leukemia | Diarrhea | Fatigue | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Risk factors | Cell adhesion & migration | Clonal deletion | Lymphocytes B | Respiratory tract diseases | Lymphomas | Pharmacokinetics | Lymphocytosis | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article